<DOC>
	<DOCNO>NCT02808988</DOCNO>
	<brief_summary>The investigator evaluate effect initial periodontal treatment clinical finding receptor activator Nuclear Factor-kappa B ligand ( RANKL ) osteoprotegerin ( OPG ) gingival crevicular fluid ( GCF ) patient osteoporosis bisphosphonate therapy within 12 month ' follow-up . Clinical recording GCF obtain postmenopausal woman ; chronic periodontitis osteoporosis ( Group A , n=13 ) , chronic periodontitis osteoporosis ( Group B , n=12 ) , without chronic periodontitis osteoporosis ( Group C , n=12 ) , systemically periodontally healthy control ( Group D , n=10 ) baseline . Recordings repeat 1st , 6th 12th month Group A , B C. RANKL OPG value measure enzyme-linked immunosorbent assay .</brief_summary>
	<brief_title>Changes GCF Levels RANKL Osteoprotegerin Postmenopausal Osteoporosis</brief_title>
	<detailed_description>The study group select postmenopausal patient refer Department Endocrinology , School Medicine , Ondokuz Mayis University . Bone mineral density ( BMD ) measurement perform dual energy-X-ray absorptiometry L1-L4 site lumbar vertebra and/or femur ( g/cm2 ) . Osteoporosis define T score less -2.5 L1-L4 , femur neck total femur . Women T score less -2.5 ( group A C ) start bisphosphonate treatment initial periodontal examination .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Women T score less 2.5 ( group A C ) The periodontitis patient select base radiographical evidence bone loss , presence four site bleed probing ( BOP ) , ≥5 mm pocket depth ( PD ) ≥6 mm clinical attachment loss ( CAL ) . The clinically healthy control group select basis radiographic bone loss CAL PD≤3 mm . Any known systemic disease rather osteoporosis Smoking Antibiotic therapy within last 3 month Periodontal treatment within last 6 month .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Bisphosphonate</keyword>
	<keyword>osteoporosis</keyword>
	<keyword>RANKL</keyword>
	<keyword>OPG</keyword>
	<keyword>periodontitis</keyword>
</DOC>